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Summary: Over a period of three years we determined haptoglobin levels by single radial immunodiffusion
(RID) and the haptoglobin phenotype in over 1700 samples of patients suspected of a haemolytic disease.
As haptoglobin phenotyping is rather laborious and therefore an expensive method, we re-evaluated the
diagnostic need for phenotyping.
From our reference values for the respective phenotypes of haptoglobin it may be theoretically argued that
phenotyping is still desirable when the RID value is in the ränge 400—1170 mg/1. Limiting ourselves to
suspected haemolytic diseases, one can abolish phenotyping beyond this narrow ränge without withdrawing
important clinical Information. From the total group it appeared that 480 samples lay in this ränge. In 72
samples (15% of 480) the evaluation of the RID values was essentially altered by phenotyping. Careful
examination of the medical records indicated that in a number of cases laborious phenotyping had indeed
contributed to the diagnosis.
Ist die Haptoglobin-Typisierung klinisch erforderlich für eine zuverlässige Bestimmung von Haptoglobin mit
der einfachen radialen Immunodiffusion?
Zusammenfassung: Wir bestimmten in über 1700 Proben von Patienten mit Verdacht auf eine hämolytische
Erkrankung während drei Jahren die Häptoglöbinkonzentration mit der einfachen radialen Immundiffusion
und zugleich den Haptoglobin^Phänotyp.
Wir prüften erneut die diagnostische Notwendigkeit der Phänotypisierung, da diese arbeitsaufwendig und
deshalb teuer ist.
Aus unseren Referenzwerten für die entsprechenden Phänotypen von Haptoglobin kann theoretisch abgelei-
tet werden, daß Phänotypisierurig noch wünschenswert ist, sofern die mit radialer Immundiffusion bestimmte
Konzentration im Bereich von 400—1170 mg/1 liegt. Bei Beschränkung auf Verdachtsfälle hämolytischer
Erkrankungen kann die Phänotypisierung oberhalb dieses schmalen Bereichs ohne Verlust wesentlicher kli-
nischer Information unterlassen werden. In diesem Bereich lagen 480 Proben der gesamten Gruppe. Bei 72
(15% von 480) Proben änderte sich aufgrund der Phänotypisierung die Beurteilung der Ergebnisse der ra-
dialen Immundiffusion. Eine sorgfältige Durchsicht der Krankenblätter zeigte, daß in einer Anzahl von
Fällen die arbeitsaufwendige Phänotypisierung tatsächlich zur Diagnose beitrug.
J. Clin. Chem. Clin. Biochern. / Vol. 22, 1984 / No. l
110 van Rijnt Kruit and Schrijver: Haptoglobin typing and determination of haptoglobin by RID
Introduction
A number of analytical methods are available to the
clinician when searching for the cause of a haemolyt-
ic disease. In cases of haemolysis, determination of
the decreased red blood cell survival and of the
number of reticulocytes can be helpful in the diagno-
sis.
However, in comparatively mild forms of a haemo-
lytic process, the reticulocyte count lacks conclusive-
ness and any diagnosis derived from it is doubtful
(D-
Recently, Marchand et al. (2) supported the routine
use of the serum haptoglobin determination in the
diagnosis of haemolytic diseases.
There exists, however, a large biological inter-indi-
vidual Variation in normals, so that the clinical use-
fulness of a single haptoglobin value has been ques-
tioned (3).
Moreover, one has to take into account the fact that
haemolytic diseases are often accompanied by in-
flammatory processes which tend to offset the lower-
ing of the haptoglobin level that goes with the hae-
molytic condition.
Besides other parameters, haptoglobin is determined
routinely in our clinic to Support the diagnosis of
haemolytic disease; for this purpose single radial im-
munodiffusion is used (4). However, in using this
technique a calculation of the exact level of hapto-
globin requires the determination of the haptoglobin
phenotype, which is time-consuming and expensive.
We therefore raised the question of whether and
when the phenotype determination can be omitted
for clinical purposes. We considered only low hapto-
globin levels, which are indicative of intravascular
haemolysis of a deficient liver haptoglobin synthesis.
Haptoglobin levels above normal, which can be in-
dicative of an inflammatory process, were not taken
into consideration.
We evaluated the serum haptoglobin levels deter-
mined over a period of three years in a wide variety
of patients with suspected haemolytic disease. All
levels without and with typing were considered, at-
tention being focussed on levels which changed from
normal to lowered and the number of levels which
changed from lowered to normal äs a result of phe-
notyping.
Materials and Methods
Reagents, equipment and methods were äs described previously
(5).
Mancin?s method (4) was used for the RID technique. Typing of
haptoglobin was done by polyacrylamide gel electrophoresis (5).
Serum samples were all from patients with suspected haemolysis.
The main findings in the peripheral blood were anaemia and/or
reticulocytosis, sometimes accompanied by elevated serum bili-
rubin levels and/or increased serum lactate dehydrogenase levels.
Results arod Discussion
During a three year period, 1744 patient samples
were received in our laboratory, 86.3% from men
and 13.7% from women. This rather unusual distri-
bution arises because the patients in our hospital are
basically army personnel.
According to the gel electrophoresis pattern six pa-
tients showed the Johnson type of haptoglobin, while
the serum haptoglobin level in 106 patients was too
low (below 200 mg/1) to determine the haptoglobin
phenotype. For the femaining 1632 samples the total
haptoglobin level (untyped) and the phenotype (1-1,
2-1 or 2-2) were determined. For the untyped hap-
toglobin level the over-all reference ränge of 500—
3300 mg/1 was used, while for the phenotypes 1-1,
2-1, and 2-2 the reference ranges were 700—2300,
900-3600 and 600-2900 mg/1 serum, respectively
(5). The factors taking into account the three pheno-
types were 0.6, 1.3, and 1.5 respectively, in accor-
dance with the Information of the manufactürer of
the RID plates. * *~
As already mentioned the aim of this retrospective
study was to answer the question of whether it is al··
ways necessary to perform a haptoglobin phenotyp-
ing. Oii theoretical grounds one can decide to per-
form phenotyping when total haptoglobin is in the
ränge 400—1170 mg/1. This idea is based on the ref-
erence ranges for the three genetic types and their
respective conversion factors and can be exemplified
äs follows.
A patient sample with a value* Hp =1160 mg/1 and
belonging to type Hp 1-1 becomes 690 ing/i when
the genetic type is taken into account. The reference
ränge for this type is 700—2300 mg/1. Hence, values
below 1170 mg/1 are "lowered" when the genetic
type is Hp 1-1 and the appropriate factor is äpplied.
It is therefore valid to question the necessity of typ-
ing all the serurn samples with values lower than
1170 mg/1. This question can be answered by consid-
ering the reference ranges of the genetic types (5, 6)
and their factors. A serum sample with a Hp value
below 400 mg/1 is "lowered" whatever the genetic
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type. Higher values come within the reference ränge
if the genetic type happens to be Hp 2-2, because the
conversion factor for this type is 1.5.
As already mentioned, if the level is above normal,
indicating for instance an acute inflammatory pto-
cess, phenotyping can also be ignored. This is be-
cause we are interested only in whether this determi-
nation supports the diagnosis of a haemolytic dis-
ease.
It appeared that in our total sample group (1632
samples) a large number (480 samples) had values
between 400 and 1170 mg/1. So if one decides to
ignore Hp phenotyping, and to perform this determi-
nation only when the values of the total haptoglobin
determination lie in the ränge 400 to 1170 rng/1, one
can considerably reduce the work load and the costs
of this test.
In this context the question arises äs to the distribu-
tion of the observed haptoglobin values both without
and with phenotyping. As can be seen from table l,
Tab. 1. The distribution of the observed total haptoglobin values
(untyped) and typed haptogiobin values of our patient
groups, according to the reference values given in the
text.
Haptoglobin Haptoglobin untyped
typed
Lowered Normal Elevated
Type 1-1
n = 255
Type 2-1
n = 757
Type 2-2
n = 620
Lowered
Normal
Elevated
Lowered
Normal
Elevated
Lowered
Normal
Elevated
3
0
0
12
0
0
29
36
0
10
175
0
26
516
46
0
395
108
0
21
46
0
0
157
0
0
52
nt = 1632
10 samples (3.9% out of 255) in the type 1-1 catego-
ry and 26 samples (3.4% out of 757) in the type 2-1
category were classified äs normal according to the
untyped reference ränge, but lowered when referring
to their phenotype ränge. In the case of type 2-2, 36
samples (5.8% out of 620) were lowered according
to the over-all reference ränge, but normal according
to the phenotype reference ränge. The other discre-
pancies are between "normal" and "above normal"
and are thus not of relevance here.
In total this means that determination of phenotype
alters the diagnosis in only 72 samples (10 of type
1-1, 26 of type 2-2 and 36 of type 2-2), which repre-
sents only 4% of the total 1632 samples and 15% of
the samples in the ränge between 400 and 1170
mg/1. In all other patient samples the influence of the
genetic type is minor, i.e. the sample values are
above or below the lower limit of the reference
ränge, whether phenotyped or not.
Another question that now arises is: within these 72
cases, how many patients with established haemolyt-
ic diseases would be diagnosed differently without
and with phenotyping? Only with these data one can
decide whether or not the phenotypic determina-
tions must be performed routinely in large groups of
persons with suspected haemolytic disease. Careful
examination of the medical records revealed that in a
number of patients the haptoglobin determination
was performed more than once, so that the 72 deter-
minations under consideration were actually per-
formed on 63 patients. It also appeared from the
medical records that only three had an established
severe haemolytic disease. The diagnoses were based
on a number of clinical features of haemolysis such
äs jaundice, hepatosplenomegaly and the laboratory
approach to the investigation of the anaemia. The
other determinations were performed for patients
with various diseases including M. Pfeiffer and Werl-
hofs disease (tab. 2).
Tab. 2. Final diagnosis in which the haptoglobin determinations
without and with phenotyping gave a different result.
Final diagnosis Haemolysis*
Haemolysis e. c. i.***
Toxoplasmosis
ß-Thalassaemia (heterozygotic)
Autoimmune haemolytic anaemia
March haemoglobinuria
General viral infection
Non haemolytic disorders
Untrackable
4
3
l
l
l
3
47
3
* + slight haemolysis
++ severe haemolysis
** In total 60 patients were investigated 69 times for serum hap-
toglobin. The medical records of 3 patients were not available.
*** e causa ignota.
Patients with a haemolysis were present in all three
categories of phenotypes. So without withdrawing
important clinical Information it appeared necessary
to perform phenotyping only for those patients with
untyped haptoglobin values lying between 400 and
1170 mg/1; these limits are calculated from the refer-
ence ranges and RIO factors of the three pheno-
types.
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With regard to the above results, the clinical chemist
can make a contribution to reducing escälating medi-
cal costs by decreasing the excessive use of diagnos-
tic tests and procedures. In addition to efforts direct-
ed at changing physician's behaviour in asking for
unnecessary or inappropiate tests, the clinical chem-
ist should also produce data that carry maximal in-
formation. So we decided in our clinic to perform
phenotyping only when the untyped values are in the
rather narrow ränge of 400 to 1170 mg/1. In this way
we reduce the workload of phenotyping by about
70%, without loss of any important clinical Informa-
tion.
Beyond the scope of this study is the question äs to
whether this test is ideal for both ruling out and con-
firming haemolysis. Such an attempt has been made
for the haptoglobin determination (2), though some
objections against this study have been reported (7).
However, with regard to the literattire and the re-
sults of our study we believe that it is permissible to
try to persuade the clinician to abolish phenotyping
and therefore accept a less quantitative result be-
yond the earlier mentioned ränge; we believe that
enough useful clinical Information is given by a result
obtained in this way.
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